The honeymoon might not be over after all for Conmed Corp. (Utica, N.Y.), which has agreed to acquire privately held Surgiquest Inc. (Milford, Conn.) for $265 million on a cash-free, debt-free basis. After Conmed's third quarter revenues came in $5 million below consensus and the company lowered its 2015 guidance, a Northland Capital Markets analyst said in a Oct. 22 report that "the honeymoon is over" for the surgical device company and lowered its price target on Conmed stock to $44 from $58. Read More
